The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Exploring the potential of endophytes from medicinal plants as sources of antimycobacterial compounds
Open accessAbstract
Natural product drug discovery has regained interest due to low production costs, structural diversity, and multiple uses of active compounds to treat various diseases. Attention has been directed towards medicinal plants as these plants have been traditionally used for generations to treat symptoms of numerous diseases. It is established that plants harbour microorganisms, collectively known as endophytes. Exploring the as-yet untapped natural products from the endophytes increases the chances of finding novel compounds. The concept of natural products targeting microbial pathogens has been applied to isolate novel antimycobacterial compounds, and the rapid development of drug-resistant Mycobacterium tuberculosis has significantly increased the need for new treatments against this pathogen. It remains important to continuously screen for novel compounds from natural sources, particularly from rarely encountered microorganisms, such as the endophytes. This review focuses on bioprospecting for polyketides and small peptides exhibiting antituberculosis activity, although current treatments against tuberculosis are described. It is established that natural products from these structure classes are often biosynthesised by microorganisms. Therefore it is hypothesised that some bioactive polyketides and peptides originally isolated from plants are in fact produced by their endophytes. This is of interest for further endophyte natural product investigations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodiversity hotspots for conservation priorities
Myers, N., Mittermeier, R. A., Mittermeier, C. G., da Fonseca, G. A. B., & Kent, J. (2000) · Nature · doi:10.1038/35002501 · Cited by 31,710
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., & McPhail, A. T. (1971) · Journal of the American Chemical Society · doi:10.1021/ja00738a045 · Cited by 4,073
Medicinal plants: Traditions of yesterday and drugs of tomorrow
Gurib-Fakim, A. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.008 · Cited by 2,391
Bioprospecting for Microbial Endophytes and Their Natural Products
Strobel, G., & Daisy, B. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.491-502.2003 · Cited by 2,359
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 1×
“Drug Sponsor Class In vitro potency Mode of action Clinical trial status TMC 207 (Bedaquiline) Janssen Diarylquinoline 30–120 ng/ml (Andries et al., 2005; Koul et al., 2008) Targeting ATP synthase, inhibition of proton pumping activity (Huitric et al., 2010) III, FDA-approved (accelerated…”
Richardson, A. E., Barea, J.-M., McNeill, A. M., & Prigent-Combaret, C. (2009) · Plant and Soil · doi:10.1007/s11104-009-9895-2 · Cited by 1,966
Fleming, A. (1929) · PubMed Central · Cited by 1,647
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Bacterial endophytes: recent developments and applications
Ryan, R. P., Germaine, K., Franks, A., Ryan, D. J., & Dowling, D. N. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2007.00918.x · Cited by 1,480
A model for the lowering of plant ethylene concentrations by plant growth-promoting bacteria
Glick, B. R., Penrose, D. M., & Li, J. (1998) · Journal of Theoretical Biology · doi:10.1006/jtbi.1997.0532 · Cited by 1,466
Natural Products from Endophytic Microorganisms
Strobel, G., Daisy, B., Castillo, U., & Harper, J. (2004) · Journal of Natural Products · doi:10.1021/np030397v · Cited by 1,465
Fischbach, M. A., & Walsh, C. T. (2006) · Chemical Reviews · doi:10.1021/cr0503097 · Cited by 1,464
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
Farnsworth, N., Akerele, O., & Bingel, A. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90016-x · Cited by 1,362
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis
Telenti, A., Imboden, P., Marchesi, F., Matter, L., Schopfer, K., Bodmer, T., Lowrie, D., Colston, M. J., & Cole, S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90417-f · Cited by 1,337
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Global tuberculosis control 2010
Behera, D. (2012) · The Indian Journal of Medical Research · Cited by 1,262
Shaw, K. J., Rather, P. N., Hare, R. S., & Miller, G. H. (1993) · Microbiological Reviews · doi:10.1128/mmbr.57.1.138-163.1993 · Cited by 1,196
Gallop, M. A., Barrett, R. W., Dower, W. J., Fodor, S. P. A., & Gordon, E. M. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00035a001 · Cited by 1,135
The challenge of new drug discovery for tuberculosis
Koul, A., Arnoult, E., Lounis, N., Guillemont, J., & Andries, K. (2011) · Nature · doi:10.1038/nature09657 · Cited by 1,042
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Endophytes as sources of bioactive products
Strobel, G. A. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00073-x · Cited by 991
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Matsumoto, M., Hashizume, H., Tomishige, T., Kawasaki, M., Tsubouchi, H., Sasaki, H., Shimokawa, Y., & Komatsu, M. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030466 · Cited by 751
Endophytic microorganisms: a review on insect control and recent advances on tropical plants
Azevedo, J. L., Maccheroni Jr., W., Pereira, J. O., & De Araújo, W. L. (2000) · Electronic Journal of Biotechnology · doi:10.2225/vol3-issue1-fulltext-4 · Cited by 735
The curious characteristics of pyrazinamide: a review.
Zhang, Y., & Mitchison, D. A. (2003) · PubMed · Cited by 723
Frieden, T. R., Sterling, T. R., Munsiff, S. S., Watt, C. J., & Dye, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14333-4 · Cited by 689
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
(2006) · Soil Biology · doi:10.1007/3-540-33526-9 · Cited by 681
Traits of fluorescent Pseudomonas spp. involved in suppression of plant root pathogens
O'Sullivan, D. J., & O'Gara, F. (1992) · Microbiological Reviews · doi:10.1128/mr.56.4.662-676.1992 · Cited by 663
Genomics of secondary metabolite production by Pseudomonas spp.
Gross, H., & Loper, J. E. (2009) · Natural Product Reports · doi:10.1039/b817075b · Cited by 628
PA-824 Kills Nonreplicating Mycobacterium tuberculosis by Intracellular NO Release
Singh, R., Manjunatha, U., Boshoff, H. I. M., Ha, Y. H., Niyomrattanakit, P., Ledwidge, R., Dowd, C. S., Lee, I. Y., Kim, P., Zhang, L., et al. (2008) · Science · doi:10.1126/science.1164571 · Cited by 628
The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism
Boshoff, H. I. M., Myers, T. G., Copp, B. R., McNeil, M. R., Wilson, M. A., & Barry, C. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406796200 · Cited by 606
Mycobacterial cell wall: Structure and role in natural resistance to antibiotics
Jarlier, V (1994) · FEMS Microbiology Letters · doi:10.1016/0378-1097(94)90267-4 · Cited by 593
Type II polyketide synthases: gaining a deeper insight into enzymatic teamwork
Hertweck, C., Luzhetskyy, A., Rebets, Y., & Bechthold, A. (2007) · Nat. Prod. Rep. · doi:10.1039/b507395m · Cited by 591
Natural products of filamentous fungi: enzymes, genes, and their regulation
Hoffmeister, D., & Keller, N. P. (2007) · Nat. Prod. Rep. · doi:10.1039/b603084j · Cited by 563
Modern Natural Products Drug Discovery and Its Relevance to Biodiversity Conservation
Kingston, D. G. I. (2011) · Journal of Natural Products · doi:10.1021/np100550t · Cited by 516
An Overview of Endophytic Microbes: Endophytism Defined
(2000) · Microbial Endophytes · doi:10.1201/9781482277302-1 · Cited by 516
Mootz, H. D., Schwarzer, D., & Marahiel, M. A. (2002) · ChemBioChem · doi:10.1002/1439-7633(20020603)3:6<490::aid-cbic490>3.0.co;2-n · Cited by 514
Tahlan, K., Wilson, R., Kastrinsky, D. B., Arora, K., Nair, V., Fischer, E., Barnes, S. W., Walker, J. R., Alland, D., Barry, C. E., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05708-11 · Cited by 504
Molecular Mechanisms of Protein Biosynthesis
(1977) · Elsevier eBooks · doi:10.1016/b978-0-12-744250-1.x5001-x · Cited by 467
Inhibitors of protein synthesis
Vazquez, D. (1974) · FEBS Letters · doi:10.1016/0014-5793(74)80689-7 · Cited by 414
Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions
Shinabarger, D. L., Marotti, K. R., Murray, R. W., Lin, A. H., Melchior, E. P., Swaney, S. M., Dunyak, D. S., Demyan, W. F., & Buysse, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2132 · Cited by 384
Diacon, A. H., Donald, P. R., Pym, A., Grobusch, M., Patientia, R. F., Mahanyele, R., Bantubani, N., Narasimooloo, R., De Marez, T., van Heeswijk, R., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06126-11 · Cited by 377
Designing screens: how to make your hits a hit
Walters, W. P., & Namchuk, M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1063 · Cited by 374
Selection of Specific Endophytic Bacterial Genotypes by Plants in Response to Soil Contamination
Siciliano, S. D., Fortin, N., Mihoc, A., Wisse, G., Labelle, S., Beaumier, D., Ouellette, D., Roy, R., Whyte, L. G., Banks, M. K., et al. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.6.2469-2475.2001 · Cited by 370
Miao, V., Coëffet-LeGal, M.-F., Brian, P., Brost, R., Penn, J., Whiting, A., Martin, S., Ford, R., Parr, I., Bouchard, M., et al. (2005) · Microbiology · doi:10.1099/mic.0.27757-0 · Cited by 368
Diarylquinolines Are Bactericidal for Dormant Mycobacteria as a Result of Disturbed ATP Homeostasis
Koul, A., Vranckx, L., Dendouga, N., Balemans, W., Van den Wyngaert, I., Vergauwen, K., Göhlmann, H. W. H., Willebrords, R., Poncelet, A., Guillemont, J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803899200 · Cited by 364 · cited 1×
“…Sponsor Class In vitro potency Mode of action Clinical trial status TMC 207 (Bedaquiline) Janssen Diarylquinoline 30–120 ng/ml (Andries et al., 2005; Koul et al., 2008) Targeting ATP synthase, inhibition of proton pumping activity (Huitric et al., 2010) III, FDA-approved (accelerated programme)…”
MethodFinken, M., Kirschner, P., Meier, A., Wrede, A., & Böttger, E. C. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01253.x · Cited by 360
Taghavi, S., Barac, T., Greenberg, B., Borremans, B., Vangronsveld, J., & van der Lelie, D. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8500-8505.2005 · Cited by 358
Multidrug-Resistant Mycobacterium tuberculosis: Molecular Perspectives
Rattan, A., Kalia, A., & Ahmad, N. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0402.980207 · Cited by 355
Bangera, M. G., & Thomashow, L. S. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.10.3155-3163.1999 · Cited by 352
Traits of fluorescent Pseudomonas spp. involved in suppression of plant root pathogens.
O’Sullivan, D. J., & O’Gara, F. (1992) · Microbiological Reviews · doi:10.1128/mmbr.56.4.662-676.1992 · Cited by 352
Bömke, C., & Tudzynski, B. (2009) · Phytochemistry · doi:10.1016/j.phytochem.2009.05.020 · Cited by 340
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
DeBarber, A. E., Mdluli, K., Bosman, M., Bekker, L.-G., & Barry, C. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9677 · Cited by 338
Biosynthesis of polyketide synthase extender units
Chan, Y. A., Podevels, A. M., Kevany, B. M., & Thomas, M. G. (2009) · Nat. Prod. Rep. · doi:10.1039/b801658p · Cited by 337
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis
Scorpio, A., Lindholm-Levy, P., Heifets, L., Gilman, R., Siddiqi, S., Cynamon, M., & Zhang, Y. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.540 · Cited by 333
Manjunatha, U. H., Boshoff, H., Dowd, C. S., Zhang, L., Albert, T. J., Norton, J. E., Daniels, L., Dick, T., Pang, S. S., & Barry, C. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508392103 · Cited by 331
Puri, S. C., Nazir, A., Chawla, R., Arora, R., Riyaz-ul-Hasan, S., Amna, T., Ahmed, B., Verma, V., Singh, S., Sagar, R., et al. (2006) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2005.10.015 · Cited by 324
Schulz, B., & Boyle, C. (2007) · Soil Biology · doi:10.1007/3-540-33526-9_1 · Cited by 319
The mechanism of action of PA-824: Novel insights from transcriptional profiling
Manjunatha, U., Boshoff, H. I. M., & Barry, C. E. (2009) · Communicative & Integrative Biology · doi:10.4161/cib.2.3.7926 · Cited by 319
Activation of the Pro-drug Ethionamide Is Regulated in Mycobacteria
Baulard, A. R., Betts, J. C., Engohang-Ndong, J., Quan, S., McAdam, R. A., Brennan, P. J., Locht, C., & Besra, G. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003744200 · Cited by 311
Mandal, S., Moudgil, M., & Mandal, S. K. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.065 · Cited by 303
Modern phytomedicine: Turning Medicinal Plants into Drugs
Ahmad, I., Aqil, F., & Owais, M. (2006) · Cited by 286
Zhang, Y., Scorpio, A., Nikaido, H., & Sun, Z. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.7.2044-2049.1999 · Cited by 285
Bioactive Molecules and Medicinal Plants
(2008) · Springer eBooks · doi:10.1007/978-3-540-74603-4 · Cited by 280
(1997) · CRC Press eBooks · doi:10.1201/9780367804558 · Cited by 279
A chain initiation factor common to both modular and aromatic polyketide synthases
Bisang, C., Long, P. F., Corte´s, J., Westcott, J., Crosby, J., Matharu, A.-L., Cox, R. J., Simpson, T. J., Staunton, J., & Leadlay, P. F. (1999) · Nature · doi:10.1038/46829 · Cited by 278
Changsen, C., Franzblau, S. G., & Palittapongarnpim, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3682-3687.2003 · Cited by 275
Pharmacognosy in the New Millennium: Leadfinding and Biotechnology
Verpoorte, R. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001773931 · Cited by 274
Wolucka, B. A., McNeil, M. R., de Hoffmann, E., Chojnacki, T., & Brennan, P. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31657-5 · Cited by 272
Discovery and Development of SQ109: A New Antitubercular Drug with a Novel Mechanism of Action
Sacksteder, K. A., Protopopova, M., Barry, C. E., Andries, K., & Nacy, C. A. (2012) · Future Microbiology · doi:10.2217/fmb.12.56 · Cited by 269
A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance
Louw, G. E., Warren, R. M., Gey van Pittius, N. C., McEvoy, C. R. E., Van Helden, P. D., & Victor, T. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01577-08 · Cited by 263
Stierle, A., Strobel, G., Stierle, D., Grothaus, P., & Bignami, G. (1995) · Journal of Natural Products · doi:10.1021/np50123a002 · Cited by 245
Ramaswamy, S. V., Amin, A. G., Göksel, S., Stager, C. E., Dou, S.-J., El Sahly, H., Moghazeh, S. L., Kreiswirth, B. N., & Musser, J. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.326-336.2000 · Cited by 240
An endophytic fungus from Azadirachta indica A. Juss. that produces azadirachtin
Kusari, S., Verma, V. C., Lamshoeft, M., & Spiteller, M. (2012) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-011-0876-2 · Cited by 238
The role of natural products in a modern drug discovery program
Strohl, W. R. (2000) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01443-9 · Cited by 234
Bacterial Endophytes as Elicitors of Induced Systemic Resistance
Kloepper, J. W., & Ryu, C.-M. (2007) · Soil Biology · doi:10.1007/3-540-33526-9_3 · Cited by 227
Getting to the bottom of Taxol biosynthesis by fungi
Heinig, U., Scholz, S., & Jennewein, S. (2013) · Fungal Diversity · doi:10.1007/s13225-013-0228-7 · Cited by 221
Huitric, E., Verhasselt, P., Koul, A., Andries, K., Hoffner, S., & Andersson, D. I. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01611-09 · Cited by 215
Mechanism of Resistance to Amikacin and Kanamycin in Mycobacterium tuberculosis
Alangaden, G. J., Kreiswirth, B. N., Aouad, A., Khetarpal, M., Igno, F. R., Moghazeh, S. L., Manavathu, E. K., & Lerner, S. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1295 · Cited by 214
Walker, K., & Croteau, R. (2001) · Phytochemistry · doi:10.1016/s0031-9422(01)00160-1 · Cited by 204
Wiyakrutta, S., Sriubolmas, N., Panphut, W., Thongon, N., Danwisetkanjana, K., Ruangrungsi, N., & Meevootisom, V. (2004) · World Journal of Microbiology and Biotechnology · doi:10.1023/b:wibi.0000023832.27679.a8 · Cited by 200
Natural product growth inhibitors of Mycobacterium tuberculosis
Copp, B. R., & Pearce, A. N. (2007) · Nat. Prod. Rep. · doi:10.1039/b513520f · Cited by 200
Aubry, A., Veziris, N., Cambau, E., Truffot-Pernot, C., Jarlier, V., & Fisher, L. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.104-112.2006 · Cited by 197
Meier, A., Kirschner, P., Springer, B., Steingrube, V. A., Brown, B. A., Wallace, R. J., & Böttger, E. C. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.381 · Cited by 195
Takayama, K., Schnoes, H. K., Armstrong, E. L., & Boyle, R. W. (1975) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36719-5 · Cited by 185
Bacterial programmed cell death systems as targets for antibiotics
Engelberg-Kulka, H., Sat, B., Reches, M., Amitai, S., & Hazan, R. (2004) · Trends in Microbiology · doi:10.1016/j.tim.2003.12.008 · Cited by 180
Control of Plant Pathogenic Fungi with Bacterial Endophytes
Berg, G., & Hallmann, J. (2007) · Soil Biology · doi:10.1007/3-540-33526-9_4 · Cited by 180
Ethnobotany: evolution of a discipline
(1996) · Choice Reviews Online · doi:10.5860/choice.34-0297 · Cited by 176
Rengarajan, J., Sassetti, C. M., Naroditskaya, V., Sloutsky, A., Bloom, B. R., & Rubin, E. J. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04120.x · Cited by 174
Pruksakorn, P., Arai, M., Kotoku, N., Vilchèze, C., Baughn, A. D., Moodley, P., Jacobs, W. R., & Kobayashi, M. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.04.100 · Cited by 172
Metabolites from the endophytic fungus Phomopsis sp. PSU-D15
Rukachaisirikul, V., Sommart, U., Phongpaichit, S., Sakayaroj, J., & Kirtikara, K. (2008) · Phytochemistry · doi:10.1016/j.phytochem.2007.09.006 · Cited by 172
Engohang‐Ndong, J., Baillat, D., Aumercier, M., Bellefontaine, F., Besra, G. S., Locht, C., & Baulard, A. R. (2004) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03809.x · Cited by 169
Unique Mechanism of Action of the Thiourea Drug Isoxyl on Mycobacterium tuberculosis
Phetsuksiri, B., Jackson, M., Scherman, H., McNeil, M., Besra, G. S., Baulard, A. R., Slayden, R. A., DeBarber, A. E., Barry, C. E., Baird, M. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m311209200 · Cited by 167
Approval of Novel TB Drug Celebrated—With Restraint
Cohen, J. (2013) · Science · doi:10.1126/science.339.6116.130 · Cited by 166 · cited 4×
“From these new rug candidates, the semi-synthetic TMC207 has received FDA pproval, specifically for patients with MDR-TB, through its accelerted approval programme which based its decision on Phase II trials Cohen, 2013; Diacon et al., 2009, 2012).”
BackgroundInfluentialInteractions between Meloidogyne incognita and endophytic bacteria in cotton and cucumber
Hallmann, J., Quadt-Hallmann, A., Rodríguez-Kábana, R., & Kloepper, J. W. (1998) · Soil Biology and Biochemistry · doi:10.1016/s0038-0717(97)00183-1 · Cited by 161
Rouse, D. A., Li, Z., Bai, G. H., & Morris, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2472 · Cited by 160
Raja, A., LaBonte, J. A., Lebbos, J., & Kirkpatrick, P. N. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1258 · Cited by 151
Yano, T., Li, L.-S., Weinstein, E., Teh, J.-S., & Rubin, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508844200 · Cited by 150
Mathys, V., Wintjens, R. T., Lefevre, P., Bertout, J., Singhal, A., Kiass, M., Kurepina, N. E., Wang, X., Mathema, B., Baulard, A. R., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01197-08 · Cited by 143
Thomas, M. G., Chan, Y. A., & Ozanick, S. G. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2823-2830.2003 · Cited by 141
Lee, R. E., Jr., Mikušová, K., Brennan, P. J., & Besra, G. S. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00153a002 · Cited by 140
First Linezolid-Resistant Clinical Isolates of Mycobacterium tuberculosis
Richter, E., Rüsch–Gerdes, S., & Hillemann, D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01113-06 · Cited by 133
Mechanisms of bacterial resistance to macrolide antibiotics
Nakajima, Y. (1999) · Journal of Infection and Chemotherapy · doi:10.1007/s101560050011 · Cited by 127
Salim, A. A., Chin, Y., & Kinghorn, A. D. (2008) · Springer eBooks · doi:10.1007/978-3-540-74603-4_1 · Cited by 124
Taubman, S. B., Jones, N. R., Young, F. E., & Corcoran, J. W. (1966) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(66)90301-7 · Cited by 108
Type I polyketide biosynthesis in bacteria (Part A — erythromycin biosynthesis) (1994 to 2000)
Rawlings, B. J. (2001) · Natural Product Reports · doi:10.1039/b009329g · Cited by 107
Felnagle, E. A., Rondon, M. R., Berti, A. D., Crosby, H. A., & Thomas, M. G. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00485-07 · Cited by 105
Cheng, Y. (2006) · ChemBioChem · doi:10.1002/cbic.200500425 · Cited by 98
Bergval, I., Schuitema, A. R. J., Klatser, P. R., & Anthony, R. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp237 · Cited by 97
Culturable Endophytes of Medicinal Plants and the Genetic Basis for Their Bioactivity
Miller, K. I., Qing, C., Sze, D., Roufogalis, B. D., & Neilan, B. A. (2012) · Microbial Ecology · doi:10.1007/s00248-012-0044-8 · Cited by 94
Self-citationTaniguchi, H., Chang, B., Abe, C., Nikaido, Y., Mizuguchi, Y., & Yoshida, S. I. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4795-4801.1997 · Cited by 91
Distinct Biological Network Properties between the Targets of Natural Products and Disease Genes
Dančík, V., Seiler, K. P., Young, D. W., Schreiber, S. L., & Clemons, P. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102798t · Cited by 88
Biodiversity, chemical diversity and drug discovery
Singh, S. B., & Peláez, F. (2007) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8117-2_4 · Cited by 83
Phonkerd, N., Kanokmedhakul, S., Kanokmedhakul, K., Soytong, K., Prabpai, S., & Kongsearee, P. (2008) · Tetrahedron · doi:10.1016/j.tet.2008.07.040 · Cited by 82
Drug Interactions in Infectious Diseases
Piscitelli, S. C., & Rodvold, K. A. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-025-4 · Cited by 82
Programming of Erythromycin Biosynthesis by a Modular Polyketide Synthase
Cane, D. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.144618 · Cited by 78
Halouska, S., Chacón, O., Fenton, R. J., Zinniel, D. K., Barletta, R. G., & Powers, R. (2007) · Journal of Proteome Research · doi:10.1021/pr0704332 · Cited by 70
Resistance to viomycin conferred by RNA of either ribosomal subunit
Yamada, T., MIZUGICHI, Y., Nierhaus, K. H., & Wittmann, H. G. (1978) · Nature · doi:10.1038/275460a0 · Cited by 69
Mukai, A., Fukai, T., Hoshino, Y., Yazawa, K., Harada, K., & Mikami, Y. (2009) · The Journal of Antibiotics · doi:10.1038/ja.2009.90 · Cited by 69
Arpha, K., Phosri, C., Suwannasai, N., Mongkolthanaruk, W., & Sodngam, S. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf302433r · Cited by 69
The chemical biology of new drugs in the development for tuberculosis
Barry, C. E., & Blanchard, J. S. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.04.008 · Cited by 68
Intrinsic Macrolide Resistance of the Mycobacterium tuberculosis Complex Is Inducible
Andini, N., & Nash, K. A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00264-06 · Cited by 66
Bioprospecting for antituberculosis leads from microbial metabolites
Ashforth, E. J., Fu, C., Liu, X., Dai, H., Song, F., Guo, H., & Zhang, L. (2010) · Natural Product Reports · doi:10.1039/c0np00008f · Cited by 66
Antimalarial and Cytotoxic Depsidones from the Fungus Chaetomium brasiliense
Khumkomkhet, P., Kanokmedhakul, S., Kanokmedhakul, K., Hahnvajanawong, C., & Soytong, K. (2009) · Journal of Natural Products · doi:10.1021/np9003189 · Cited by 64
Peptide antibiotics of the tuberactinomycin family as inhibitors of group I intron RNA splicing
Wank, H., Rogers, J., DAVIES, J. E., & Schroeder, R. (1994) · Journal of Molecular Biology · doi:10.1016/0022-2836(94)90007-8 · Cited by 63
Haritakun, R., Sappan, M., Suvannakad, R., Tasanathai, K., & Isaka, M. (2009) · Journal of Natural Products · doi:10.1021/np900520b · Cited by 62
Alahari, A., Alibaud, L., Trivelli, X., Gupta, R., Lamichhane, G., Reynolds, R. C., Bishai, W. R., Guérardel, Y., & Kremer, L. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2009.06604.x · Cited by 62
Dual actions of viomycin on the ribosomal functions
Liou, Y., & Tanaka, N. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(76)90812-3 · Cited by 59
Natural Products as Leads for Tuberculosis Drug Development
Salomon, C. E., & Schmidt, L. E. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612799984526 · Cited by 55
Cheng, M., Wu, M., Yanai, H., Su, Y., Chen, I., Yuan, G., Hsieh, S., & Chen, J. (2012) · Phytochemistry Letters · doi:10.1016/j.phytol.2012.04.007 · Cited by 53
Jones, D. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3957 · Cited by 52
Mycobacterium tuberculosis in the post-genomic age
Domenech, P., Barry, C. E., & Cole, S. T. (2001) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00160-0 · Cited by 48
Ramariolides A–D, Antimycobacterial Butenolides Isolated from the Mushroom Ramaria cystidiophora
Centko, R. M., Ramón‐García, S., Taylor, T., Patrick, B. O., Thompson, C. J., Miao, V., & Andersen, R. J. (2012) · Journal of Natural Products · doi:10.1021/np3006277 · Cited by 47
Limyati, D. A., & Juniar, B. L. L. (1998) · Journal of Ethnopharmacology · doi:10.1016/s0378-8741(98)00082-8 · Cited by 43
Lanostane-Type Triterpenes from the Mushroom Astraeus pteridis with Antituberculosis Activity
Stanikunaite, R., Radwan, M. M., Trappe, J. M., Fronczek, F. R., & Ross, S. A. (2008) · Journal of Natural Products · doi:10.1021/np800577p · Cited by 42
First novel anti-tuberculosis drug in 40 years
Osborne, R. (2013) · Nature Biotechnology · doi:10.1038/nbt0213-89 · Cited by 42
Bioactive Compounds from the Scale Insect Pathogenic Fungus Conoideocrella tenuis BCC 18627
Isaka, M., Palasarn, S., Supothina, S., Komwijit, S., & Luangsa-ard, J. J. (2011) · Journal of Natural Products · doi:10.1021/np100849x · Cited by 38
Steffan, B., Wätjen, W., Michels, G., Niering, P., Wray, V., Ebel, R., Edrada‐Ebel, R., Kahl, R., & Proksch, P. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357055317 · Cited by 32
Two novel nucleosidyl–peptide antibiotics: Sansanmycin F and G produced by Streptomyces sp SS
Xie, Y., Xu, H., Sun, C., Yu, Y., & Chen, R. (2010) · The Journal of Antibiotics · doi:10.1038/ja.2010.6 · Cited by 31
Ramiferin, a bisphenol-sesquiterpene from the fungus Kionochaeta ramifera BCC 7585
Bunyapaiboonsri, T., Veeranondha, S., Boonruangprapa, T., & Somrithipol, S. (2008) · Phytochemistry Letters · doi:10.1016/j.phytol.2008.09.008 · Cited by 23
In-vitro and intracellular antimycobacterial activity of trifluoperazine
REDDY, M. V., Nadadhur, G., & Gangadharam, P. R. (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/37.1.196 · Cited by 20
Current problems with tuberculosis treatment
Grosset, J. H. E. (1996) · Research in Microbiology · doi:10.1016/0923-2508(96)80197-5 · Cited by 14
Maroz, A., Shinde, S. S., Franzblau, S. G., Ma, Z., Denny, W. A., Palmer, B. D., & Anderson, R. F. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b915877d · Cited by 13
Amaral, L. (2012) · Biochemistry & Pharmacology Open Access · doi:10.4172/2167-0501.1000e102 · Cited by 10
Danziger, L. H., & Neuhauser, M. M. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-213-7_7 · Cited by 7
Schaeffer, M. L., Carson, J. D., Kallender, H., & Lonsdale, J. T. (2004) · Tuberculosis · doi:10.1016/j.tube.2004.03.001 · Cited by 7
Cited by
Plant beneficial endophytic bacteria: Mechanisms, diversity, host range and genetic determinants
Afzal, I., Shinwari, Z. K., Sikandar, S., & Shahzad, S. (2019) · Microbiological Research · doi:10.1016/j.micres.2019.02.001 · Cited by 1,010
Endophytes: A Treasure House of Bioactive Compounds of Medicinal Importance
Gouda, S., Das, G., Sen, S. K., Shin, H.-S., & Patra, J. K. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01538 · Cited by 869
Anand, U., Jacobo-Herrera, N., Altemimi, A., & Lakhssassi, N. (2019) · Metabolites · doi:10.3390/metabo9110258 · Cited by 867
Beneficial role of bacterial endophytes in heavy metal phytoremediation
Ma, Y., Rajkumar, M., Zhang, C., & Freitas, H. (2016) · Journal of Environmental Management · doi:10.1016/j.jenvman.2016.02.047 · Cited by 684
A critical review on exploiting the pharmaceutical potential of plant endophytic fungi
Gupta, S., Chaturvedi, P., Kulkarni, M. G., & Van Staden, J. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107462 · Cited by 346
Metadata
- Authors
- Alvin, A., Miller, K. I., & Neilan, B. A.
- Venue
- Microbiological Research
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 169
- Issue
- 7-8
- Pages
- 483-495
- ISSN
- 0944-5013 (ISSN-L)
- OpenAlex
- W2061043967
- Cited by
- 373
- References
- 149
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.